NIMGenetics expands into Europe with purchase of Gene Predictis
NIMGenetics, a Spanish biotech company dedicated to human genetic diagnostics and a SEBiot partner, continues its expansion in Europe with the acquisition of the Swiss diagnostic company Gene Predictis, a leader in the field of preventive health and precision medicine.
With this acquisition, NIMGenetics aims to strengthen its international expansion, with a focus on Central European markets. Thanks to the synergies of both companies’ portfolios and the strong customer growth they have experienced in recent years, NIMGenetics will position itself with this acquisition in a leading position in the European genetic diagnostics market.
The location of Gene Predictis in the EPFL Innovation Park in Lausanne (Ecole Polytechnique Fédérale de Lausanne) will allow the Spanish biotech company to position itself in a context with a strong innovative component, within an environment focused on the biotech, pharmaceutical and food tech industries.
For more information, click here.